TickerFactsScreenerDevelopers

Relay Therapeutics, Inc. (RLAY) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$66.13M2020: -$102.49M2021: -$74.41M2022: -$229.49M2023: -$300.32M2024: -$249.11M2025: -$235.46M-$235.46M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$235.46M+5.5%
2024-$249.11M+17.1%
2023-$300.32M-30.9%
2022-$229.49M-208.4%
2021-$74.41M+27.4%
2020-$102.49M-55.0%
2019-$66.13M—